Diagnostic tests

Not very long ago, we highlighted the advent of a new blood test to detect colon cancer. While we made clear its accuracy in detecting early-stage colon cancer is not equal to that of a traditional colonoscopy, for those who have not undergone a colonoscopy or other screening tests, it…

Not very long ago we brought you the news that a new blood test had been developed to test for colorectal (CRC) cancer. This past week, the FDA approved the test, called Shield, produced by the drug manufacturer Guardant. Endorsed by both the American Cancer Society and the US Preventive…

If it feels like there’s an onslaught of information these days about how to diagnose and treat Alzheimer’s dementia, your feelings are valid. New developments and research are coming fast and furious, as academic researchers and for-profit companies race to find effective ways to diagnose Alzheimer’s as early as possible…

In the evolving landscape of the diagnosis and treatment of Alzheimer’s, updates and insights are regularly advancing. We’ve previously reported on the introduction and demise of the first breakthrough “treatment”- Aduhelm- and then on the introduction of Leqembi, the IV-administered antibody intended to slow down the pace of cognitive decline…

Just in time to raise awareness during National Colorectal Cancer Awareness Month, a new study in the New England Journal of Medicine reports that a blood test has now been developed to detect the presence of colorectal cancer, becoming another tool to identify what has been described as the second…

Last summer, we reported on the FDA approval of Leqembi, a medication that slows down cognitive decline in patients with Mild Cognitive Impairment or early Alzheimer’s Disease. While the medication is now covered by Medicare, patients who want access still have to demonstrate a diagnosis of Alzheimer’s and still have…